Skip to main content
letter
. 2018 Feb 15;8(2):21. doi: 10.1038/s41408-018-0058-7

Fig. 1. Risk-stratified Kaplan–Meier survival curves for 19 CSF3R-mutated CNL patients.

Fig. 1

Points were attributed for ROC analysis-defined cut-offs of platelet count <160 × 109/L (2 points), leukocyte count >60 × 109/L (1 point) and presence of ASXL1 mutation (1 point) according to their respective risks ratios and patients stratified into low-risk (0–1 points) or high-risk (2–4 points) groups using this prognostic risk model (log rank p = 0.0016)